RESEARCH TRIANGLE PARK, N.C.--Duke University researcher Allen Roses has been named director of Glaxo Wellcome's $48 million international genetics program. He will be based in the company's U.S. headquarters here and continue working at Duke as an adjunct professor. Previously, Glaxo Wellcome had funded Roses's Alzheimers research.
The Glaxo Wellcome genetics program employs 150 researchers in laboratories in the U.S., the U.K., and Switzerland. The company has said it expects the size of the department to double over the next 18 months.